Haemonetics Corp. (HAE)
122.06
+3.37
(+2.84%)
USD |
NYSE |
Oct 12, 16:00
122.06
0.00 (0.00%)
After-Hours: 20:00
Haemonetics Free Cash Flow (Quarterly) : 44.42M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 44.42M |
| March 31, 2026 | 53.28M |
| December 31, 2025 | 87.22M |
| September 30, 2025 | 106.30M |
| June 30, 2025 | 13.64M |
| March 31, 2025 | 100.91M |
| December 31, 2024 | 35.22M |
| September 30, 2024 | 39.39M |
| June 30, 2024 | -33.08M |
| March 31, 2024 | 54.40M |
| December 31, 2023 | -22.83M |
| September 30, 2023 | 74.47M |
| June 30, 2023 | 9.423M |
| March 31, 2023 | 66.57M |
| December 31, 2022 | 47.57M |
| September 30, 2022 | 51.08M |
| June 30, 2022 | -3.474M |
| March 31, 2022 | 32.94M |
| December 31, 2021 | 35.77M |
| September 30, 2021 | 22.65M |
| June 30, 2021 | -15.60M |
| March 31, 2021 | -10.08M |
| December 31, 2020 | 56.92M |
| September 30, 2020 | 20.82M |
| June 30, 2020 | 4.116M |
| Date | Value |
|---|---|
| March 31, 2020 | 35.76M |
| December 31, 2019 | 58.89M |
| September 30, 2019 | 20.43M |
| June 30, 2019 | -5.621M |
| March 31, 2019 | 6.922M |
| December 31, 2018 | 28.92M |
| September 30, 2018 | 8.869M |
| June 30, 2018 | -4.392M |
| March 31, 2018 | 38.52M |
| December 31, 2017 | 38.82M |
| September 30, 2017 | 43.50M |
| June 30, 2017 | 24.70M |
| March 31, 2017 | 18.96M |
| December 31, 2016 | 36.31M |
| September 30, 2016 | 20.12M |
| June 30, 2016 | 8.216M |
| March 31, 2016 | 24.72M |
| December 31, 2015 | 8.11M |
| September 30, 2015 | 1.627M |
| June 30, 2015 | -15.00M |
| March 31, 2015 | 33.62M |
| December 31, 2014 | -2.765M |
| September 30, 2014 | -2.545M |
| June 30, 2014 | -23.35M |
| March 31, 2014 | 21.54M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| ICU Medical, Inc. | 59.99M |
| Merit Medical Systems, Inc. | 51.08M |
| Teleflex, Inc. | 80.30M |
| Globus Medical, Inc. | 176.57M |
| Abbott Laboratories | 1.991B |